Accuray (ARAY) Competitors

Accuray (NASDAQ:ARAY) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation, community ranking and institutional ownership.

Does the MarketBeat Community prefer ARAY or UTMD?

Accuray received 178 more outperform votes than Utah Medical Products when rated by MarketBeat users. Likewise, 65.61% of users gave Accuray an outperform vote while only 61.60% of users gave Utah Medical Products an outperform vote.

Company	Underperform	Outperform
Accuray	Outperform Votes 332 65.61%	Underperform Votes 174 34.39%
Utah Medical Products	Outperform Votes 154 61.60%	Underperform Votes 96 38.40%

Do institutionals & insiders hold more shares of ARAY or UTMD?

64.1% of Accuray shares are owned by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are owned by institutional investors. 4.2% of Accuray shares are owned by insiders. Comparatively, 6.6% of Utah Medical Products shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Is ARAY or UTMD more profitable?

Utah Medical Products has a net margin of 34.62% compared to Accuray's net margin of -3.72%. Utah Medical Products' return on equity of 12.10% beat Accuray's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accuray	-3.72%	-36.93%	-3.52%
Utah Medical Products	34.62%	12.10%	11.50%

Which has preferable earnings and valuation, ARAY or UTMD?

Utah Medical Products has lower revenue, but higher earnings than Accuray. Accuray is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accuray	$446.55M	0.43	-$15.55M	-$0.17	-11.35
Utah Medical Products	$50.22M	4.41	$16.64M	$4.27	15.29

Does the media favor ARAY or UTMD?

In the previous week, Accuray had 10 more articles in the media than Utah Medical Products. MarketBeat recorded 11 mentions for Accuray and 1 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 1.54 beat Accuray's score of 0.27 indicating that Utah Medical Products is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accuray	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Utah Medical Products	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has more risk and volatility, ARAY or UTMD?

Accuray has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500.

Do analysts prefer ARAY or UTMD?

Accuray presently has a consensus target price of $9.00, suggesting a potential upside of 366.32%. Given Accuray's stronger consensus rating and higher possible upside, analysts clearly believe Accuray is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accuray	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Utah Medical Products	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Utah Medical Products beats Accuray on 10 of the 18 factors compared between the two stocks.